1.2. Analysis.
Comparison 1 Rivastigmine (capsules 6 to 12 mg/day in two divided doses or 10 cm2 (9.5 mg/day) patch) versus placebo, Outcome 2 MMSE (change from baseline at 24‐26 weeks) ITT.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.